GlaxoSmithKline Biologicals S.A. (Batch release of finished product, release of solvent batches in ampoules and syringes; labeling and packaging of solvent in ampoules, quality control of solvent in ampoules, labeling and packaging of solvent in syringes, quality control of solvent in syringes, vaccine quality control, labeling and packaging of finished product) / Catalent Belgium (Manufacturing of solvent in syringes, quality control of solvent in syringes)
UkraineAll medications by this manufacturer
-
Varilrix™/varilrix™ vaccine for prevention of varicella live attenuated
Form: lyophilisate for solution for injection
Active substance Dosage live attenuated varicella virus Oka strain not less than 103.3 IU ATC: J07BK01